In vivo biologic activity of induced hybrid TREG/Th2 RAPA-501 cells for als therapy: correction of TSCM:TEMimbalance, normalization of IL-6 secretion, and reduction in serum NF-L levels

In vivo biologic activity of induced hybrid TREG/Th2 RAPA-501 cells for als therapy: correction of TSCM:TEMimbalance, normalization of IL-6 secretion, and reduction in serum NF-L levels

Saved in:
Bibliographic Details
Published in:Cytotherapy (Oxford, England) Vol. 23; no. 5; p. S102
Main Authors: Felizardo, T., Lum, L.G., Ashmaig, M., Mosquera Limas, S., Zhu, N., Bushera, H., Glass, D., Berry, J., Korngold, R., Donato, M., Glass, J., Munshi, P., Rowley, S., Fowler, D.H.
Format: Journal Article
Language:English
Published: Elsevier Inc 01-05-2021
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1465-3249
1477-2566
DOI:10.1016/S146532492100431X